788 related articles for article (PubMed ID: 22261438)
1. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation.
Gordon SM; Chaix J; Rupp LJ; Wu J; Madera S; Sun JC; Lindsten T; Reiner SL
Immunity; 2012 Jan; 36(1):55-67. PubMed ID: 22261438
[TBL] [Abstract][Full Text] [Related]
2. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow.
Daussy C; Faure F; Mayol K; Viel S; Gasteiger G; Charrier E; Bienvenu J; Henry T; Debien E; Hasan UA; Marvel J; Yoh K; Takahashi S; Prinz I; de Bernard S; Buffat L; Walzer T
J Exp Med; 2014 Mar; 211(3):563-77. PubMed ID: 24516120
[TBL] [Abstract][Full Text] [Related]
3. T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells.
Kiekens L; Van Loocke W; Taveirne S; Wahlen S; Persyn E; Van Ammel E; De Vos Z; Matthys P; Van Nieuwerburgh F; Taghon T; Van Vlierberghe P; Vandekerckhove B; Leclercq G
Front Immunol; 2021; 12():732511. PubMed ID: 34630413
[TBL] [Abstract][Full Text] [Related]
4. Sequential actions of EOMES and T-BET promote stepwise maturation of natural killer cells.
Zhang J; Le Gras S; Pouxvielh K; Faure F; Fallone L; Kern N; Moreews M; Mathieu AL; Schneider R; Marliac Q; Jung M; Berton A; Hayek S; Vidalain PO; Marçais A; Dodard G; Dejean A; Brossay L; Ghavi-Helm Y; Walzer T
Nat Commun; 2021 Sep; 12(1):5446. PubMed ID: 34521844
[TBL] [Abstract][Full Text] [Related]
5. Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells.
Tayade C; Fang Y; Black GP; V A P; Erlebacher A; Croy BA
J Leukoc Biol; 2005 Dec; 78(6):1347-55. PubMed ID: 16204645
[TBL] [Abstract][Full Text] [Related]
6. Stage-Specific Requirement for Eomes in Mature NK Cell Homeostasis and Cytotoxicity.
Wagner JA; Wong P; Schappe T; Berrien-Elliott MM; Cubitt C; Jaeger N; Lee M; Keppel CR; Marin ND; Foltz JA; Marsala L; Neal CC; Sullivan RP; Schneider SE; Keppel MP; Saucier N; Cooper MA; Fehniger TA
Cell Rep; 2020 Jun; 31(9):107720. PubMed ID: 32492428
[TBL] [Abstract][Full Text] [Related]
7. T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1.
Zhang J; Marotel M; Fauteux-Daniel S; Mathieu AL; Viel S; Marçais A; Walzer T
Eur J Immunol; 2018 May; 48(5):738-750. PubMed ID: 29424438
[TBL] [Abstract][Full Text] [Related]
8. Eomesodermin and T-bet mark developmentally distinct human natural killer cells.
Collins A; Rothman N; Liu K; Reiner SL
JCI Insight; 2017 Mar; 2(5):e90063. PubMed ID: 28289707
[TBL] [Abstract][Full Text] [Related]
9. Differential requirement for Nfil3 during NK cell development.
Seillet C; Huntington ND; Gangatirkar P; Axelsson E; Minnich M; Brady HJ; Busslinger M; Smyth MJ; Belz GT; Carotta S
J Immunol; 2014 Mar; 192(6):2667-76. PubMed ID: 24532575
[TBL] [Abstract][Full Text] [Related]
10. Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage.
Pikovskaya O; Chaix J; Rothman NJ; Collins A; Chen YH; Scipioni AM; Vivier E; Reiner SL
J Immunol; 2016 Feb; 196(4):1449-54. PubMed ID: 26792802
[TBL] [Abstract][Full Text] [Related]
11. T-BET and EOMES sustain mature human NK cell identity and antitumor function.
Wong P; Foltz JA; Chang L; Neal CC; Yao T; Cubitt CC; Tran J; Kersting-Schadek S; Palakurty S; Jaeger N; Russler-Germain DA; Marin ND; Gang M; Wagner JA; Zhou AY; Jacobs MT; Foster M; Schappe T; Marsala L; McClain E; Pence P; Becker-Hapak M; Fisk B; Petti AA; Griffith OL; Griffith M; Berrien-Elliott MM; Fehniger TA
J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37279078
[TBL] [Abstract][Full Text] [Related]
12. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
[TBL] [Abstract][Full Text] [Related]
13. CXCR6 marks a novel subset of T-bet(lo)Eomes(hi) natural killer cells residing in human liver.
Stegmann KA; Robertson F; Hansi N; Gill U; Pallant C; Christophides T; Pallett LJ; Peppa D; Dunn C; Fusai G; Male V; Davidson BR; Kennedy P; Maini MK
Sci Rep; 2016 May; 6():26157. PubMed ID: 27210614
[TBL] [Abstract][Full Text] [Related]
14. Technical Advance: Fluorescent reporter reveals insights into eomesodermin biology in cytotoxic lymphocytes.
Paley MA; Gordon SM; Bikoff EK; Robertson EJ; Wherry EJ; Reiner SL
J Leukoc Biol; 2013 Feb; 93(2):307-15. PubMed ID: 23192430
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-Based Generation of CD49a
Ni X; Fu B; Zhang J; Sun R; Tian Z; Wei H
Front Immunol; 2018; 9():2126. PubMed ID: 30319610
[TBL] [Abstract][Full Text] [Related]
16. Cutting Edge: Divergent Requirement of T-Box Transcription Factors in Effector and Memory NK Cells.
Madera S; Geary CD; Lau CM; Pikovskaya O; Reiner SL; Sun JC
J Immunol; 2018 Mar; 200(6):1977-1981. PubMed ID: 29440505
[TBL] [Abstract][Full Text] [Related]
17. Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation.
Robbins SH; Tessmer MS; Van Kaer L; Brossay L
Eur J Immunol; 2005 Mar; 35(3):757-65. PubMed ID: 15719366
[TBL] [Abstract][Full Text] [Related]
18. KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinoma.
Malaisé M; Rovira J; Renner P; Eggenhofer E; Sabet-Baktach M; Lantow M; Lang SA; Koehl GE; Farkas SA; Loss M; Agha A; Campistol JM; Schlitt HJ; Geissler EK; Kroemer A
J Immunol; 2014 Feb; 192(4):1954-61. PubMed ID: 24415778
[TBL] [Abstract][Full Text] [Related]
19. Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection.
van Helden MJ; Goossens S; Daussy C; Mathieu AL; Faure F; Marçais A; Vandamme N; Farla N; Mayol K; Viel S; Degouve S; Debien E; Seuntjens E; Conidi A; Chaix J; Mangeot P; de Bernard S; Buffat L; Haigh JJ; Huylebroeck D; Lambrecht BN; Berx G; Walzer T
J Exp Med; 2015 Nov; 212(12):2015-25. PubMed ID: 26503444
[TBL] [Abstract][Full Text] [Related]
20. CXCR6
Angelo LS; Bimler LH; Nikzad R; Aviles-Padilla K; Paust S
Front Immunol; 2019; 10():469. PubMed ID: 30941128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
